Stone House Investment Management »

Viking Therapeutics shares owned by Stone House Investment Management

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Stone House Investment Management from 13F filings

Historical chart of Stone House Investment Management investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Stone House Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Stone House Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $32k 500 63.31
2024-03-31 $25k 300 82.00
2023-12-31 $4.7k 250 18.61
2023-09-30 $2.8k 250 11.07
2023-06-30 $4.1k 250 16.21

More positions owned by Stone House Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Total Usd (IUSB)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Procter & Gamble Company (PG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Eafe Grwth Etf (EFG)
Ishares Tr Core Msci Total (IXUS)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr Mbs Etf (MBB)
Ishares Msci Emrg Chn (EMXC)
Ishares Tr U.s. Tech Etf (IYW)
Ishares Tr Core Us Aggbd Et (AGG)

View all positions for Stone House Investment Management

Top funds holding Viking Therapeutics

Vanguard Group
BlackRock
BlackRock
State Street Corporation
Susquehanna International
Citadel Advisors
Jpmorgan Chase & Co
Geode Capital Management
Perceptive Advisors
Pictet Asset Management Holding SA
Perpetual
Alliancebernstein
Goldman Sachs Group
Braidwell
Jane Street

View all funds holding Viking Therapeutics